Endothelin inhibits cholangiocarcinoma growth by a decrease in the vascular endothelial growth factor expression
about
Histamine regulation of hyperplastic and neoplastic cell growth in cholangiocytes.Recent advances in the regulation of cholangiocarcinoma growthThe challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer.Detection of Autoantibodies to Vascular Endothelial Growth Factor Receptor-3 in Bile Duct Ligated Rats and Correlations with a Panel of Traditional Markers of Liver Diseases.Liver carcinogenesis: rodent models of hepatocarcinoma and cholangiocarcinoma.Autocrine regulation of biliary pathology by activated cholangiocytes.Expression of vascular endothelial growth factors and their receptors by hepatic progenitor cells in human liver diseases.Vascular factors, angiogenesis and biliary tract diseaseExpert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).Disease control with sunitinib in advanced intrahepatic cholangiocarcinoma resistant to gemcitabine-oxaliplatin chemotherapy.Cholangiocarcinoma pathogenesis: Role of the tumor microenvironment.Unveiling the role of tumor reactive stroma in cholangiocarcinoma: an opportunity for new therapeutic strategies.Genotyping and mRNA profiling reveal actionable molecular targets in biliary tract cancers.Reactive Ductules Are Associated With Angiogenesis and Tumor Cell Proliferation in Pediatric Liver CancerMolecular pathogenesis of cholangiocarcinoma
P2860
Q33909909-25C78A9A-02A4-4EE0-8956-F9B2D7D2AC84Q33994814-6F499CA7-280A-404A-97EC-0DBA6EDA0798Q36683019-CB91BA97-F878-45BE-B81F-6CB5571DCC45Q36880742-2D533548-4F92-4D6D-9D9E-DFE62FE7FF88Q37028411-A1D4F239-1E69-4B13-B1ED-8C9DA35A7910Q37175512-5CA1C14E-69AF-40C2-BCDC-51FC2062DE4FQ37584658-1C18DD8B-8D51-4DDF-9A8D-819A581C0969Q37671557-EB017889-FA9E-4A35-865C-14386CBAA437Q38812588-570EAE70-9036-48BB-8ECA-A8A976C03C09Q39995898-999C635C-B8CF-4FB3-9218-94D3CB039F6CQ42029380-CBCE9E0A-D3FD-4A57-B724-AA3B8A4F11DFQ42272472-87483586-6176-436A-90A3-D76FA65842FBQ50127508-FE39FFA5-4C57-4648-AE37-9247795217C9Q57069778-E98746C9-C9BF-454D-985E-07F88B4BAFFAQ58704494-4AE712FA-668A-4004-8697-A25E297E41D0
P2860
Endothelin inhibits cholangiocarcinoma growth by a decrease in the vascular endothelial growth factor expression
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Endothelin inhibits cholangioc ...... elial growth factor expression
@en
Endothelin inhibits cholangioc ...... lial growth factor expression.
@nl
type
label
Endothelin inhibits cholangioc ...... elial growth factor expression
@en
Endothelin inhibits cholangioc ...... lial growth factor expression.
@nl
prefLabel
Endothelin inhibits cholangioc ...... elial growth factor expression
@en
Endothelin inhibits cholangioc ...... lial growth factor expression.
@nl
P2093
P2860
P50
P1433
P1476
Endothelin inhibits cholangioc ...... elial growth factor expression
@en
P2093
Antonio Benedetti
Eugenio Gaudio
Giammarco Fava
Gianfranco Alpini
Heather Francis
Luca Marucci
Marco Marzioni
Monique Coufal
Shannon Glaser
Sharon Demorrow
P2860
P304
P356
10.1111/J.1478-3231.2009.01997.X
P577
2009-03-09T00:00:00Z